Heartsciences Inc. income statement

In fiscal 2026, Heartsciences Inc. reported revenue of $4,319, down 0.7% on the year before, operating income of −$8.4m (a -194787.4% margin) and net income of −$9.1m. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Heartsciences Inc.: income statement, annual
Fiscal year	2022Apr 2022	2023Apr 2023	2024Apr 2024	2025Apr 2025	2026Apr 2026	LTMJul 2026
Revenue	0	0	0	0	0	0
Cost of revenue	0	0	0	0	0	0
Gross profit	0	0	0	0	0	0
Research and development	3	2	3	4	3	3
Selling, general and administrative	2	4	3	4	6	7
Operating income	−5	−6	−6	−8	−8	−9
Interest expense	0	0	0	1	1	1
Income tax	—	—	—	0	0	—
Net income	−5	−6	−7	−9	−9	−10
Diluted EPS	−$1.45	−$80.00	−$18.74	−$9.34	—	−$3.19
Diluted shares (average)	—	—	—	—	3m	3m
EBITDA	−5	−6	−6	−8	−8	−9

US$ thousands unless shown otherwise. Fiscal quarters.

Heartsciences Inc.: income statement, quarterly
Quarter	2024 Q4Apr 2024	2025 Q3Jan 2025	2025 Q4Apr 2025	2026 Q1Jul 2025	2026 Q2Oct 2025	2026 Q3Jan 2026	2026 Q4Apr 2026	2027 Q1Jul 2026
Revenue	0	0	4	2	2	0	0	2
Cost of revenue	0	0	2	1	1	0	0	1
Gross profit	0	0	2	1	1	0	0	1
Research and development	1,046	1,033	929	997	727	639	476	907
Selling, general and administrative	834	1,338	994	878	1,348	1,290	2,060	2,034
Operating income	−1,880	−2,371	−1,920	−1,874	−2,073	−1,929	−2,536	−2,939
Interest expense	21	179	181	184	280	62	228	235
Net income	−1,846	−2,536	−2,094	−2,055	−2,351	−1,985	−2,751	−3,172
Diluted EPS	$0.11	−$2.57	−$1.88	−$1.58	−$0.85	—	—	—
EBITDA	−1,871	−2,365	−1,913	−1,867	−2,066	−1,922	−2,530	−2,933

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: CUPR vs HSCS HSCS vs POAS HSCS vs PAVM

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Heartsciences Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Heartsciences Inc.